Given the key role of IL6 in supporting MM survival and proliferation [47,48], and our observation that BMP2 and BMP6 reduced IL6 expression in MSCs, we next assessed whether they could directly counteract IL6-induced myeloma growth. Here, IL6 is linked to Miyoshi myopathy.